NanJing Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
NanJing Pharmaceutical Co Ltd cash flow reinvestment rate. NanJing Pharmaceutical Co Ltd (600713) has a Cash Flow Reinvestment Rate of 0.01x as of December 2024, reinvesting CN¥67.25 Million (capex CN¥66.16 Million plus investments CN¥-1.09 Million) from operating cash flow of CN¥5.03 Billion. Explore how well can NanJing Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of NanJing Pharmaceutical Co Ltd (1998–2024)
Cash flow reinvestment rate of NanJing Pharmaceutical Co Ltd from 1998 to 2024. Historical reinvestment intensity for NanJing Pharmaceutical Co Ltd across 18 annual periods. Explore capital reinvestment ratio of NanJing Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
NanJing Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (1998–2024)
NanJing Pharmaceutical Co Ltd cash flow reinvestment rate by year from 1998 to 2024. Year-by-year capital reinvestment analysis for NanJing Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of NanJing Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥569.02 Million | CN¥2.14 Billion | CN¥544.76 Million | ▲ +53.3% |
| 2023 | 0.17x | CN¥331.39 Million | CN¥1.91 Billion | CN¥158.22 Million | ▼ -65.4% |
| 2021 | 0.50x | CN¥349.27 Million | CN¥695.33 Million | CN¥306.54 Million | ▲ +67.6% |
| 2019 | 0.30x | CN¥300.81 Million | CN¥1.00 Billion | CN¥300.71 Million | ▼ -63.4% |
| 2017 | 0.82x | CN¥261.83 Million | CN¥319.99 Million | CN¥240.57 Million | ▼ -49.2% |
| 2012 | 1.61x | CN¥270.72 Million | CN¥168.17 Million | CN¥270.72 Million | ▼ -30.2% |
| 2010 | 2.31x | CN¥274.50 Million | CN¥119.08 Million | CN¥274.50 Million | ▼ -68.3% |
| 2009 | 7.27x | CN¥146.97 Million | CN¥20.22 Million | CN¥146.97 Million | ▼ -73.1% |
| 2008 | 27.07x | CN¥117.12 Million | CN¥4.33 Million | CN¥117.12 Million | ▲ +2499.4% |
| 2007 | 1.04x | CN¥84.42 Million | CN¥81.08 Million | CN¥84.42 Million | ▲ +316.0% |
| 2006 | 0.25x | CN¥40.38 Million | CN¥161.31 Million | CN¥40.38 Million | ▼ -16.8% |
| 2005 | 0.30x | CN¥49.80 Million | CN¥165.57 Million | CN¥49.80 Million | ▼ -95.1% |
| 2004 | 6.19x | CN¥100.72 Million | CN¥16.26 Million | CN¥100.72 Million | ▲ +61.4% |
| 2003 | 3.84x | CN¥73.91 Million | CN¥19.27 Million | CN¥73.91 Million | ▲ +33.7% |
| 2002 | 2.87x | CN¥197.26 Million | CN¥68.75 Million | CN¥197.26 Million | ▲ +818.3% |
| 2000 | 0.31x | CN¥27.40 Million | CN¥87.68 Million | CN¥27.40 Million | ▼ -41.6% |
| 1999 | 0.54x | CN¥27.06 Million | CN¥50.58 Million | CN¥27.06 Million | ▼ -45.7% |
| 1998 | 0.99x | CN¥76.39 Million | CN¥77.45 Million | CN¥76.39 Million | — |